Infectious Disease Puscast #95

On episode #95 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 11/20/25 – 12/3/25.

Host: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Viral
• Early low-dose dexamethasone is associated with shorter acute symptom duration in Chikungunya virus infection: a retrospective cohort study (BMC Infectious Diseases)
• Noninferiority of One HPV Vaccine Dose to Two Doses (NEJM)
• Evidence to Action — Single-Dose HPV Vaccination and Cervical HPV Infection (NEJM)
• Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human InfectionModel (NEJM)
• Universal Hepatitis B Vaccination at Birth—Risks of Revising the recommendation (JAMA)
• Correlates of HIV-1 control after combination immunotherapy (Nature)
• Human-to-Human Rabies Transmission via Solid Organ Transplantation from a Donor with Undiagnosed Rabies — United States, October 2024–February 2025 (CDC: MMWR)
• Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients (CID)
• An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant (CID)
• Bacterial
• Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update (CID)
• Lyme DiseaseIncidence in Massachusetts, 2012-2024 (JAMA: Open Network)
• Fungal
• The Last of US Season 2 (YouTube)
• Aspergillosis-Attributable Mortality in the United States: Analysis of Death CertificateData (CID)
• Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial (LANCET: Infectious Diseases)
• Parasitic
• Loa loa encephalopathy following treatment with benzimidazole derivatives: A systematic review (OFID)

Music is by Ronald Jenkees

Information on this podcast should not be considered as medical advice.